Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network

JM Heard, C Vrinten, M Schlander, CM Bellettato, C Lingen, M Scarpa, Hidde Huidekoper, U Groselj, MZ Tansek

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Article number3
JournalOrphanet Journal of Rare Diseases
Issue number1
Publication statusPublished - 2020

Cite this